Remote Patient Monitoring Frequency Calculator
Determines the recommended remote monitoring frequency based on clinical risk factors including condition severity, vital sign stability, recent medication changes, and comorbidity burden.
Formula
Composite Risk Score = (Condition Severity × 3) + (Vital Instability × 2.5) + (Medication Risk × 2) + (Comorbidities × 1.5) + (Adherence Risk × 1.5) + Age Modifier
Age Modifier: <40 → 0 | 40–64 → 1 | 65–79 → 2 | ≥80 → 3
Maximum possible score: (4×3) + (3×2.5) + (3×2) + (3×1.5) + (2×1.5) + 3 = 34.5
| Score Range | Risk Level | Monitoring Frequency |
|---|---|---|
| 0 – 7 | Low | Monthly (every 30 days) |
| 8 – 13 | Moderate | Bi-weekly (every 14 days) |
| 14 – 19 | High | Weekly (every 7 days) |
| 20 – 26 | Very High | Every 2–3 days |
| ≥ 27 | Critical | Daily monitoring |
Assumptions & References
- Weighting factors are derived from clinical risk stratification frameworks used in chronic disease management and RPM programme design.
- Condition severity weights (×3) reflect its primary role as the strongest predictor of monitoring need, consistent with CMS RPM billing guidelines (CPT 99457/99458).
- Vital sign instability (×2.5) is weighted based on evidence that early detection of deteriorating vitals reduces hospitalisation rates by 15–25% (Klersy et al., 2009, JACC).
- Medication change risk (×2) reflects pharmacovigilance requirements, particularly for high-alert medications (ISMP High-Alert Medication List).
- Comorbidity burden (×1.5) is consistent with the Charlson Comorbidity Index approach to risk adjustment.
- Adherence/engagement (×1.5) reflects that low-adherence patients require more frequent contact to ensure data completeness and safety.
- Age modifier reflects increased physiological vulnerability and higher hospitalisation risk in older adults (≥65), per CDC chronic disease surveillance data.
- This calculator does not replace clinical assessment. Clinicians should use professional judgement and consider patient-specific factors not captured here.
- References: AHA/ACC Heart Failure Guidelines (2022); CMS RPM Policy (2023); Klersy C. et al. JACC 2009; ISMP High-Alert Medications; Charlson ME et al. J Chronic Dis 1987.